{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:27:32Z","timestamp":1794025652969,"version":"4.8.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaccas.2026.110573","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:49:04Z","timestamp":1792111744000},"page":"110573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative B-Cell\u2013Targeted Therapy for High-Risk Valve Surgery in Active Primary Sj\u00f6gren's Disease"],"prefix":"10.1016","author":[{"given":"Bing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaccas.2026.110573_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/1570161118666200129125320","article-title":"Primary Sj\u00f6gren\u2019s syndrome and cardiovascular disease","volume":"18","author":"Melissaropoulos","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"issue":"24","key":"10.1016\/j.jaccas.2026.110573_bib2","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.jacc.2022.08.004","article-title":"2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on clinical practice guidelines","volume":"80","author":"Isselbacher","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jaccas.2026.110573_bib3","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jtcvs.2009.11.068","article-title":"A case of Sj\u00f6gren\u2019s syndrome leading to mitral and aortic valve replacement","volume":"139","author":"Bridge","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.jaccas.2026.110573_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1536\/ihj.15-349","article-title":"Aortic stenosis in a patient with Sjogren's syndrome","volume":"57","author":"Kono","year":"2016","journal-title":"Int Heart J"},{"issue":"6","key":"10.1016\/j.jaccas.2026.110573_bib5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/08923973.2021.1973493","article-title":"Telitacicept as a BLyS\/APRIL dual inhibitor for autoimmune disease","volume":"43","author":"Shi","year":"2021","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jaccas.2026.110573_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaccas.2026.110573_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/rheumatology\/kead265","article-title":"Efficacy and safety of telitacicept in primary Sj\u00f6gren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial","volume":"63","author":"Xu","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaccas.2026.110573_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00059-013-4038-1","article-title":"Role of anticardiolipin antibodies in the pathogenesis of prosthetic valve thrombosis: an observational study","volume":"40","author":"Aykan","year":"2015","journal-title":"Herz"},{"issue":"3","key":"10.1016\/j.jaccas.2026.110573_bib9","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1097\/JS9.0000000000004164","article-title":"Long-term outcomes of mitral valve replacement in patients with systemic autoimmune disease: a nationwide retrospective cohort study","volume":"112","author":"Chan","year":"2026","journal-title":"Int J Surg"},{"key":"10.1016\/j.jaccas.2026.110573_bib10","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926037344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926037344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:19:38Z","timestamp":1794025178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084926037344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":10,"alternative-id":["S2666084926037344"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.110573","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative B-Cell\u2013Targeted Therapy for High-Risk Valve Surgery in Active Primary Sj\u00f6gren's Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.110573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"110573"}}